Publication: Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations
Open/View Files
Date
2013
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Ophthalmic Research Center
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Nassiri, Nariman, Medi Eslani, Nekoo Panahi, Shiva Mehravaran, Alireza Ziaei, and Ali R. Djalilian. 2013. “Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations.” Journal of Ophthalmic & Vision Research 8 (4): 351-358.
Research Data
Abstract
Graft versus host disease (GVHD) is a common complication of allogeneic stem cell transplantation (allo-SCT). Ocular GVHD develops in approximately 40-60% of patients following allo-SCT and its most common clinical manifestations include keratoconjunctivitis sicca and cicatricial conjunctivitis. Ocular GVHD may lead to severe ocular surface disease, which can significantly diminish quality of life and restrict daily activities. It is thus important to monitor the condition closely since with timely diagnosis, irreversible damage can be avoided. The current review will focus on updated information regarding ocular GVHD.
Description
Other Available Sources
Keywords
Allogeneic Stem Cell Transplantation, Bone Marrow Transplantation, Ocular Graft Versus Host Disease, Dry Eye, Keratoconjunctivitis Sicca
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service